0001181431-12-040421.txt : 20120711 0001181431-12-040421.hdr.sgml : 20120711 20120711170325 ACCESSION NUMBER: 0001181431-12-040421 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120709 FILED AS OF DATE: 20120711 DATE AS OF CHANGE: 20120711 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FERRARI LOUIS CENTRAL INDEX KEY: 0001513697 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 12958132 MAIL ADDRESS: STREET 1: 765 WARREN STREET CITY: WARRREN STREET STATE: NJ ZIP: 07090 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd350893.xml FERRARI FORM 4 X0306 4 2012-07-09 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001513697 FERRARI LOUIS SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 President and CEO Option to Purchase Common Stock, $.01 par value 0.56 2012-07-09 4 A 0 150000 0.56 A 2013-07-09 2022-07-09 Common Stock, $.01 par value per share 150000 150000 D These options shall vest and become exercisable as to 75,000 shares on each of July 9, 2013 and July 9, 2014, provided the optionee remains employed by the Company on these dates /s/ Irina Ishak for Louis Ferrari 2012-07-11